Selegiline reduces daytime sleepiness in patients with Parkinson's disease
Sign Up to like & getrecommendations! Published in 2021 at "Brain and Behavior"
DOI: 10.1002/brb3.1880
Abstract: Excessive daytime sleepiness (EDS) affects a large percentage of Parkinson's disease (PD) patients, and it is enhanced by dopamine agonist drugs. Currently, there is no treatment of choice for EDS in PD. Our aim was… read more here.
Keywords: patients parkinson; sleepiness patients; daytime sleepiness; parkinson disease ... See more keywords